Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: potential solutions to current and future challenges
暂无分享,去创建一个
Lang Tran | Nicklas Raun Jacobsen | Steffen Loft | Giulio Pojana | Helinor Johnston | Stefano Zuin | Peter Møller | Manuela Semmler-Behnke | Catherine McGuiness | Dominique Balharry | Antonio Marcomini | Håkan Wallin | Wolfgang Kreyling | Ken Donaldson | Vicki Stone | W. Kreyling | G. Pojana | A. Marcomini | N. Jacobsen | H. Wallin | P. Møller | S. Loft | K. Donaldson | V. Stone | M. Semmler-Behnke | L. Tran | H. Johnston | Stefano Zuin | D. Balharry | Catherine McGuiness
[1] Andrew D Maynard,et al. Exposure Assessment Approaches for Engineered Nanomaterials , 2010, Risk analysis : an official publication of the Society for Risk Analysis.
[2] D. Warheit,et al. Comparative pulmonary toxicity assessments of C60 water suspensions in rats: few differences in fullerene toxicity in vivo in contrast to in vitro profiles. , 2007, Nano letters.
[3] Craig A. Poland,et al. Zeta potential and solubility to toxic ions as mechanisms of lung inflammation caused by metal/metal oxide nanoparticles. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.
[4] H Salem,et al. Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[5] A. T. Saber,et al. Inflammatory and genotoxic effects of nanoparticles designed for inclusion in paints and lacquers , 2012, Nanotoxicology.
[6] P. Baron,et al. Exposure to Carbon Nanotube Material: Assessment of Nanotube Cytotoxicity using Human Keratinocyte Cells , 2003, Journal of toxicology and environmental health. Part A.
[7] Magnus Svartengren,et al. No Significant Translocation of Inhaled 35-nm Carbon Particles to the Circulation in Humans , 2006, Inhalation toxicology.
[8] Keith Guy,et al. The impact of different nanoparticle surface chemistry and size on uptake and toxicity in a murine macrophage cell line. , 2008, Toxicology and applied pharmacology.
[9] David E Newby,et al. Do inhaled carbon nanoparticles translocate directly into the circulation in humans? , 2006, American journal of respiratory and critical care medicine.
[10] Younan Xia,et al. Gold nanostructures: a class of multifunctional materials for biomedical applications. , 2011, Chemical Society reviews.
[11] David Brown,et al. Investigating the relationship between nanomaterial hazard and physicochemical properties: Informing the exploitation of nanomaterials within therapeutic and diagnostic applications. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[12] N. Jacobsen,et al. Role of oxidative damage in toxicity of particulates , 2010, Free radical research.
[13] Richard Owen,et al. Strategic Approaches for the Management of Environmental Risk Uncertainties Posed by Nanomaterials , 2009 .
[14] A. Boxall,et al. Detection and characterization of engineered nanoparticles in food and the environment , 2008, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.
[15] Antonio Nunes,et al. Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. , 2011, The American journal of pathology.
[16] Jürgen Seitz,et al. Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs , 2009, Inhalation toxicology.
[17] Vicki H Grassian,et al. Commercially manufactured engineered nanomaterials for environmental and health studies: Important insights provided by independent characterization , 2010, Environmental toxicology and chemistry.
[18] Helinor J Johnston,et al. A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity , 2010, Critical reviews in toxicology.
[19] W. MacNee,et al. Particulate air pollution and acute health effects , 1995, The Lancet.
[20] Zissis Samaras,et al. Hazard and Risk Assessment of a Nanoparticulate Cerium Oxide-Based Diesel Fuel Additive—A Case Study , 2008, Inhalation toxicology.
[21] Joel G Pounds,et al. ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies , 2010, Particle and Fibre Toxicology.
[22] Günter Oberdörster,et al. Toxicology of ultrafine particles: in vivo studies , 2000 .
[23] Vicki Stone,et al. Current hypotheses on the mechanisms of toxicity of ultrafine particles. , 2003, Annali dell'Istituto superiore di sanita.
[24] R. Aitken,et al. Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[25] J. James,et al. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[26] Vicki Stone,et al. Toxicology of nanoparticles: A historical perspective , 2007 .
[27] G. Oberdörster,et al. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles , 1996 .
[28] Helinor J Johnston,et al. A critical review of the biological mechanisms underlying the in vivo and in vitro toxicity of carbon nanotubes: The contribution of physico-chemical characteristics , 2010, Nanotoxicology.
[29] T. Webb,et al. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[30] Manuela Semmler-Behnke,et al. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[31] Kyunghee Choi,et al. Induction of inflammatory responses and gene expression by intratracheal instillation of silver nanoparticles in mice , 2011, Archives of pharmacal research.
[32] Gerhard Scheuch,et al. Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery. , 2008, American journal of respiratory and critical care medicine.
[33] Vicki Stone,et al. Identification of the mechanisms that drive the toxicity of TiO2 particulates: the contribution of physicochemical characteristics , 2009, Particle and Fibre Toxicology.
[34] Vicki Stone,et al. Nano-silver – feasibility and challenges for human health risk assessment based on open literature , 2010, Nanotoxicology.
[35] Nicklas Raun Jacobsen,et al. Mutation spectrum in FE1‐MUTATMMouse lung epithelial cells exposed to nanoparticulate carbon black , 2011, Environmental and molecular mutagenesis.
[36] Steffen Loft,et al. Pulmonary exposure to carbon black nanoparticles and vascular effects , 2010, Particle and Fibre Toxicology.
[37] Vicki Stone,et al. Interspecies comparisons on the uptake and toxicity of silver and cerium dioxide nanoparticles , 2012, Environmental toxicology and chemistry.
[38] W. MacNee,et al. The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area , 2007, Occupational and Environmental Medicine.
[39] Pratim Biswas,et al. Assessing the relevance of in vitro studies in nanotoxicology by examining correlations between in vitro and in vivo data. , 2012, Toxicology.
[40] J. West,et al. The Differential Cytotoxicity of Water-Soluble Fullerenes , 2004 .
[41] Mark Bradley,et al. Metal Oxide Nanoparticles Induce Unique Inflammatory Footprints in the Lung: Important Implications for Nanoparticle Testing , 2010, Environmental health perspectives.
[42] Manuela Semmler-Behnke,et al. Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration , 2011, Nanotoxicology.
[43] D. Dockery,et al. Epidemiology of Particle Effects , 1999 .
[44] Lang Tran,et al. Evaluating the uptake and intracellular fate of polystyrene nanoparticles by primary and hepatocyte cell lines in vitro. , 2010, Toxicology and applied pharmacology.
[45] P. Baron,et al. Exposure to Carbon Nanotube Material: Aerosol Release During the Handling of Unrefined Single-Walled Carbon Nanotube Material , 2004, Journal of toxicology and environmental health. Part A.
[46] Mary Gulumian,et al. The limits of testing particle-mediated oxidative stress in vitro in predicting diverse pathologies; relevance for testing of nanoparticles , 2009, Particle and Fibre Toxicology.
[47] Craig A. Poland,et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. , 2008, Nature nanotechnology.
[48] Yongjun Li,et al. Comparative study of pathological lesions induced by multiwalled carbon nanotubes in lungs of mice by intratracheal instillation and inhalation , 2007, Environmental toxicology.
[49] Christian Micheletti,et al. Analysis of currently available data for characterising the risk of engineered nanomaterials to the environment and human health--lessons learned from four case studies. , 2011, Environment international.
[50] Jürgen Seitz,et al. A generator for the production of radiolabelled ultrafine carbonaceous particles for deposition and clearance studies in the respiratory tract , 2006 .
[51] H. Krug,et al. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. , 2006, Nano letters.
[52] Vicki Stone,et al. The biological mechanisms and physicochemical characteristics responsible for driving fullerene toxicity. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.
[53] Vincent Castranova,et al. Dispersion of single-walled carbon nanotubes by a natural lung surfactant for pulmonary in vitro and in vivo toxicity studies , 2010, Particle and Fibre Toxicology.
[54] Nicklas Raun Jacobsen,et al. Biodistribution of gold nanoparticles in mouse lung following intratracheal instillation , 2009, Chemistry Central journal.
[55] David M. Brown,et al. Proinflammogenic Effects of Low-Toxicity and Metal Nanoparticles In Vivo and In Vitro: Highlighting the Role of Particle Surface Area and Surface Reactivity , 2007, Inhalation toxicology.
[56] David M. Brown,et al. Measurement of reactive species production by nanoparticles prepared in biologically relevant media. , 2007, Toxicology letters.
[57] Iseult Lynch,et al. The evolution of the protein corona around nanoparticles: a test study. , 2011, ACS nano.
[58] D. Weed. Weight of Evidence: A Review of Concept and Methods , 2005, Risk analysis : an official publication of the Society for Risk Analysis.
[59] Keishiro Tomoda,et al. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. , 2008, Colloids and surfaces. B, Biointerfaces.
[60] Nicklas Raun Jacobsen,et al. Increased mutant frequency by carbon black, but not quartz, in the lacZ and cII transgenes of muta™mouse lung epithelial cells , 2007, Environmental and molecular mutagenesis.
[61] Manuela Semmler-Behnke,et al. Biodistribution of 1.4- and 18-nm gold particles in rats. , 2008, Small.
[62] David B Warheit,et al. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[63] Karluss Thomas,et al. Moving toward exposure and risk evaluation of nanomaterials: challenges and future directions. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[64] R. Scholz,et al. Modeled environmental concentrations of engineered nanomaterials (TiO(2), ZnO, Ag, CNT, Fullerenes) for different regions. , 2009, Environmental science & technology.
[65] Steffen Loft,et al. Hazard identification of particulate matter on vasomotor dysfunction and progression of atherosclerosis , 2011, Critical reviews in toxicology.
[66] Vicki Stone,et al. Nano-TiO2 – feasibility and challenges for human health risk assessment based on open literature , 2010, Nanotoxicology.
[67] G. Oberdorster,et al. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles. , 1996, Inhalation toxicology.
[68] A. Peters,et al. Respiratory effects are associated with the number of ultrafine particles. , 1997, American journal of respiratory and critical care medicine.
[69] G. Oberdörster,et al. Pulmonary retention of ultrafine and fine particles in rats. , 1992, American journal of respiratory cell and molecular biology.
[70] Hassan S. Bazzi,et al. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots , 2005, Journal of Molecular Medicine.
[71] Lang Tran,et al. Safe handling of nanotechnology , 2006, Nature.
[72] H. Norppa,et al. Risk assessment of engineered nanomaterials and nanotechnologies--a review. , 2010, Toxicology.
[73] Nicklas Raun Jacobsen,et al. Lung inflammation and genotoxicity following pulmonary exposure to nanoparticles in ApoE-/- mice , 2009, Particle and Fibre Toxicology.
[74] S. Bhatia,et al. Probing the Cytotoxicity Of Semiconductor Quantum Dots. , 2004, Nano letters.
[75] Güunter Oberdürster. Toxicology of ultrafine particles: in vivo studies , 2000, Philosophical Transactions of the Royal Society of London. Series A: Mathematical, Physical and Engineering Sciences.
[76] B. Nowack,et al. Exposure modeling of engineered nanoparticles in the environment. , 2008, Environmental science & technology.
[77] Kiril Hristovski,et al. The release of nanosilver from consumer products used in the home. , 2010, Journal of environmental quality.
[78] Petra Krystek,et al. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. , 2008, Biomaterials.
[79] G. Oberdörster,et al. Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.
[80] M. Prato,et al. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[81] Peter Gehr,et al. A three-dimensional cellular model of the human respiratory tract to study the interaction with particles. , 2005, American journal of respiratory cell and molecular biology.
[82] Claus-Michael Lehr,et al. An in vitro triple cell co-culture model with primary cells mimicking the human alveolar epithelial barrier. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[83] P. Møller,et al. Oxidative stress generated damage to DNA by gastrointestinal exposure to insoluble particles. , 2012, Current molecular medicine.
[84] Vicki Stone,et al. An in vitro study of the potential of carbon nanotubes and nanofibres to induce inflammatory mediators and frustrated phagocytosis , 2007 .
[85] Joel G Pounds,et al. Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[86] D. Mitchell,et al. Special report of the Massachusetts weight‐of‐evidence workgroup A weight‐of‐evidence approach for evaluating ecological risks , 1996 .
[87] N. Bottini,et al. Multi-walled carbon nanotubes induce T lymphocyte apoptosis. , 2006, Toxicology letters.
[88] Steffen Loft,et al. Oxidatively Damaged DNA in Rats Exposed by Oral Gavage to C60 Fullerenes and Single-Walled Carbon Nanotubes , 2008, Environmental health perspectives.
[89] Steffen Loft,et al. Modest vasomotor dysfunction induced by low doses of C60 fullerenes in apolipoprotein E knockout mice with different degree of atherosclerosis , 2009, Particle and Fibre Toxicology.
[90] Ron C. Hardman. A Toxicologic Review of Quantum Dots: Toxicity Depends on Physicochemical and Environmental Factors , 2005, Environmental health perspectives.
[91] Nebojsa Romcevic,et al. Inactivation of nanocrystalline C60 cytotoxicity by gamma-irradiation. , 2006, Biomaterials.
[92] P. Borm,et al. Concordance Between In Vitro and In Vivo Dosimetry in the Proinflammatory Effects of Low-Toxicity, Low-Solubility Particles: The Key Role of the Proximal Alveolar Region , 2008, Inhalation toxicology.
[93] Jo Anne Shatkin,et al. Nanomaterials: Risks and Benefits, NATO Science for Peace and Security Series C: Environmental Security , 2009 .
[94] P. Biswas,et al. Concept of Assessing Nanoparticle Hazards Considering Nanoparticle Dosemetric and Chemical/Biological Response Metrics , 2010, Journal of toxicology and environmental health. Part A.
[95] Robert Gelein,et al. EXTRAPULMONARY TRANSLOCATION OF ULTRAFINE CARBON PARTICLES FOLLOWING WHOLE-BODY INHALATION EXPOSURE OF RATS , 2002, Journal of toxicology and environmental health. Part A.
[96] Zissis Samaras,et al. Hazard and risk assessment of a nanoparticulate cerium oxide-based diesel fuel additive - a case study. , 2008, Inhalation toxicology.
[97] Nancy A Monteiro-Riviere,et al. Fullerene-based amino acid nanoparticle interactions with human epidermal keratinocytes. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.
[98] B. Rothen‐Rutishauser,et al. A newly developed in vitro model of the human epithelial airway barrier to study the toxic potential of nanoparticles. , 2008, ALTEX.
[99] P. Baron,et al. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[100] Sir,et al. Nanotechnology in perspective. Risks to man and the environment , 2009 .
[101] David B Warheit,et al. How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[102] Vicki Stone,et al. An in vitro liver model - assessing oxidative stress and genotoxicity following exposure of hepatocytes to a panel of engineered nanomaterials , 2012, Particle and Fibre Toxicology.
[103] Jongheop Yi,et al. Oxidative stress and apoptosis induced by titanium dioxide nanoparticles in cultured BEAS-2B cells. , 2008, Toxicology letters.
[104] Junko Nakanishi,et al. Fullerene c60: inhalation hazard assessment and derivation of a period-limited acceptable exposure level. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[105] Paul Westerhoff,et al. Nanoparticle silver released into water from commercially available sock fabrics. , 2008, Environmental science & technology.
[106] W. MacNee,et al. Short-term inflammatory responses following intratracheal instillation of fine and ultrafine carbon black in rats. , 1999, Inhalation toxicology.
[107] Miroslav D. Dramićanin,et al. Inactivation of nanocrystalline C60 cytotoxicity by γ-irradiation , 2006 .
[108] P. Herckes,et al. Detection of fullerenes (C60 and C70) in commercial cosmetics. , 2011, Environmental pollution.
[109] Antonio Marcomini,et al. Genotoxicity, cytotoxicity, and reactive oxygen species induced by single‐walled carbon nanotubes and C60 fullerenes in the FE1‐Muta™Mouse lung epithelial cells , 2008, Environmental and molecular mutagenesis.
[110] C. L. Tran,et al. Concordance Between In Vitro and In Vivo Dosimetry in the Proinflammatory Effects of Low-Toxicity, Low-Solubility Particles: The Key Role of the Proximal Alveolar Region , 2008 .
[111] David M. Brown,et al. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. , 2001, Toxicology and applied pharmacology.
[112] Jeffery A. Steevens,et al. Potential for Occupational Exposure to Engineered Carbon-Based Nanomaterials in Environmental Laboratory Studies , 2009, Environmental health perspectives.
[113] M. Prato,et al. Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes. , 2005, Angewandte Chemie.
[114] Vicki Stone,et al. Review of fullerene toxicity and exposure--appraisal of a human health risk assessment, based on open literature. , 2010, Regulatory toxicology and pharmacology : RTP.
[115] Helinor J Johnston,et al. Review of carbon nanotubes toxicity and exposure—Appraisal of human health risk assessment based on open literature , 2010, Critical reviews in toxicology.
[116] Maria Dusinska,et al. Nanomaterials for environmental studies: classification, reference material issues, and strategies for physico-chemical characterisation. , 2010, The Science of the total environment.
[117] Vicki Stone,et al. Assessing exposure, uptake and toxicity of silver and cerium dioxide nanoparticles from contaminated environments , 2009, Environmental health : a global access science source.
[118] Lang Tran,et al. Surface derivatization state of polystyrene latex nanoparticles determines both their potency and their mechanism of causing human platelet aggregation in vitro. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[119] Christian Micheletti,et al. Weight of Evidence approach for the relative hazard ranking of nanomaterials , 2011, Nanotoxicology.
[120] Miran Kwon,et al. Exposure assessment of workplaces manufacturing nanosized TiO2 and silver , 2011, Inhalation toxicology.